Guinea vs Syrian Arab Republic: Hepatitis B surface antigen (HBsAg) prevalence
Guinea
2.8%
in 2024
Syrian Arab Republic
2.9%
in 2024
Guinea rank
7th
Syrian Arab Republic rank
6th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Guinea
- Syrian Arab Republic
How they compare
Syrian Arab Republic currently reports 2.9% against 2.8% in Guinea, a difference of 0.1%.
Across all 10 years both countries report, Syrian Arab Republic has been ahead every year.
Guinea ranks 7th and Syrian Arab Republic ranks 6th of 194 countries.
Syrian Arab Republic has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Guinea | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.7% | 3.5% | 0.7% | Syrian Arab Republic |
| 2020s | 2.7% | 3.4% | 0.7% | Syrian Arab Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Guinea or Syrian Arab Republic?
- Syrian Arab Republic, at 2.9% against 2.8% in Guinea as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Guinea and Syrian Arab Republic?
- 0.1%, with Syrian Arab Republic ahead.
- How many years of comparable data are there for Guinea and Syrian Arab Republic?
- 10 years are reported by both, from 2015 to 2024.
- How do Guinea and Syrian Arab Republic rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Guinea ranks 7th and Syrian Arab Republic ranks 6th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.